AngioDynamics (NASDAQ:ANGO – Get Rating) updated its FY 2023 earnings guidance on Friday. The company provided EPS guidance of -$0.06–$0.01 for the period, compared to the consensus EPS estimate of -$0.01. The company issued revenue guidance of $338.00 million-$342.00 million, compared to the consensus revenue estimate of $342.47 million. Analyst Upgrades and Downgrades A number […]
AngioDynamics (NASDAQ:ANGO – Get Rating) posted its quarterly earnings results on Thursday. The medical instruments supplier reported ($0.03) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.02), Briefing.com reports. AngioDynamics had a negative net margin of 9.98% and a negative return on equity of 0.14%. The business had revenue of […]
AngioDynamics (NASDAQ:ANGO – Get Rating) posted its quarterly earnings results on Thursday. The medical instruments supplier reported ($0.03) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.02), Briefing.com reports. The business had revenue of $80.70 million during the quarter, compared to analysts’ expectations of $83.20 million. AngioDynamics had a negative […]
AngioDynamics (NASDAQ:ANGO – Get Rating) issued an update on its FY 2023 earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of -$0.06–$0.01 for the period, compared to the consensus estimate of -$0.01. The company issued revenue guidance of $338.00 million-$342.00 million, compared to the consensus revenue estimate of $342.47 million. […]
AngioDynamics (NASDAQ:ANGO – Get Rating) and Beauty Health (NASDAQ:SKIN – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, analyst recommendations, earnings, risk and institutional ownership. Earnings and Valuation This table compares AngioDynamics and Beauty Health’s […]